Charles Riv­er buys KWS BioTest for $20M, gain­ing im­munol­o­gy dis­cov­ery ca­pac­i­ty and a UK foot­print

In a move to ex­pand its dis­cov­ery en­ter­prise, Charles Riv­er Lab­o­ra­to­ries $CRL has ac­quired KWS BioTest for £15 mil­lion (rough­ly $20 mil­lion) up front. …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.